Drug Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Drug Development stocks.

Drug Development Stocks Recent News

Date Stock Title
May 15 PTN Palatin Technologies, Inc. (PTN) Q3 2024 Earnings Call Transcript
May 15 LDOS 5 Dividend Stocks to Boost Portfolio Growth
May 15 PTN Palatin Tech GAAP EPS of -$0.53 misses by $0.03
May 15 PTN Palatin Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
May 15 BLTE Belite Bio, Inc 2024 Q1 - Results - Earnings Call Presentation
May 15 BLTE Belite Bio, Inc (BLTE) Q1 2024 Earnings Call Transcript
May 14 BLTE Belite Bio reports Q1 results
May 14 PTN Palatin Tech Q3 2024 Earnings Preview
May 14 LDOS Leidos (LDOS) Wins $631M Deal to Aid US Army's DIABLO Program
May 14 BLTE Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
May 14 LDOS Leidos and Elroy Air to demonstrate autonomous aerial resupply drone for U.S. Marine Corps
May 14 ME Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
May 14 CDXS Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
May 14 BLTE Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
May 13 BLTE Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
May 13 LDOS Zacks.com featured highlights Hasbro, Brinker International, DaVita, Leidos Holdings and Allstate
May 10 ME Struggling 23andMe Granted Extension to Revive Stock Price
May 10 LDOS 5 Stocks Trading Near 52-Week High With More Upside Potential
May 9 ONCT Oncternal Therapeutics, Inc. (ONCT) Q1 2024 Earnings Call Transcript
May 9 ONCT Oncternal Therapeutics GAAP EPS of -$2.83 beats by $0.05, revenue of $0.57M beats by $0.44M
Drug Development

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

Browse All Tags